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Abstract
Background:  Although exposure to asbestos is now regulated, patients continue to be diagnosed with
mesothelioma, asbestosis, fibrosis and lung carcinoma because of the long latent period between exposure and
clinical disease. Asbestosis is observed in approximately 200,000 patients annually and asbestos-related deaths are
estimated at 4,000 annually[1]. Although advances have been made using single gene/gene product or pathway
studies, the complexity of the response to asbestos and the many unanswered questions suggested the need for
a systems biology approach. The objective of this study was to generate a comprehensive view of the
transcriptional changes induced by crocidolite asbestos in A549 human lung epithelial cells.
Results: A statistically robust, comprehensive data set documenting the crocidolite-induced changes in the A549
transcriptome was collected. A systems biology approach involving global observations from gene ontological
analyses coupled with functional network analyses was used to explore the effects of crocidolite in the context
of known molecular interactions. The analyses uniquely document a transcriptome with function-based networks
in cell death, cancer, cell cycle, cellular growth, proliferation, and gene expression. These functional modules show
signs of a complex interplay between signaling pathways consisting of both novel and previously described
asbestos-related genes/gene products. These networks allowed for the identification of novel, putative
crocidolite-related genes, leading to several new hypotheses regarding genes that are important for the asbestos
response. The global analysis revealed a transcriptome that bears signatures of both apoptosis/cell death and cell
survival/proliferation.
Conclusion: Our analyses demonstrate the power of combining a statistically robust, comprehensive dataset and
a functional network genomics approach to 1) identify and explore relationships between genes of known
importance 2) identify novel candidate genes, and 3) observe the complex interplay between genes/gene products
that function in seemingly different processes. This study represents the first function-based global approach
toward understanding the response of human lung epithelial cells to the carcinogen crocidolite. Importantly, our
investigation paints a much broader landscape for the crocidolite response than was previously appreciated and
reveals novel paths to study. Our graphical representations of the function-based global network will be a valuable
resource to model new research findings.
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Background
Asbestos is a family of naturally occurring silicate miner-
als that was once used extensively in a variety of building
materials and industries and is still found in older struc-
tures. Exposure to certain forms of asbestos, such as croc-
idolite and amosite, have been shown to cause
mesothelioma, asbestosis, fibrosis and carcinoma of the
lungs, esophagus and stomach [2-4]. Many developing
countries continue to mine and use asbestos, presenting a
continued risk to individuals.
The biodurability and chemical reactivity of crocidolite
asbestos, taken together, create a formidable carcinogen
for the human lung to handle. Crocidolite can induce
DNA strand breaks and base alterations. One expected
response to this damage is apoptosis/cell death. But under
certain conditions, cell replication can occur before the
DNA damage is repaired, resulting in the formation of
mutations. Events which promote survival of the cell with
DNA damage and stimulate replication may lead to can-
cer. An unfortunate consequence of apoptosis is the stim-
ulation of surrounding cells to replicate in an effort to
repair the integrity of the damaged tissue. If the surround-
ing cells have experienced DNA damage, the result could
be mutations, which may lead to cancer. What sets croci-
dolite apart from most other carcinogens is the persistent
nature of the inhaled fibers, allowing for continued dam-
age to surviving cells throughout the lifetime of the indi-
vidual. Therefore, knowledge of the delicate balance
between pathways that lead to proliferation or survival
and those which lead to apoptosis or cell death are crucial
for understanding the etiologies behind several asbestos-
induced lung disorders and diseases.
Much of the deleterious effects of asbestos can be attrib-
uted to the sustained synthesis of reactive oxygen species
(ROS) which in turn results in DNA damage [5-7] and oxi-
dative stress within the cell. Iron associated with the fibers
(up to 27% by weight in crocidolite) can participate in
Fenton and Haber-Weiss chemistry and therefore plays an
intimate role in ROS generation (reviewed by [8]). Signals
which reduce glutathione synthesis and increase efflux of
reduced glutathione result in the reduction of intracellular
glutathione concentrations [9], thus, exacerbating the sit-
uation. At the crux of the decision to initiate apoptosis is
a p53-dependent transcription response. Although the
events upstream of p53 activation and the importance of
p53 targets are not well characterized, the result of p53
activation is mitochondrial dysfunction leading to apop-
tosis [10]. Apoptosis prevents continued proliferation of
the damaged cell, but factors released from the damaged
cell can also affect nearby cells causing inflammation and
proliferation. In mapping the signal cascades which are
activated/deactivated by asbestos, both human and non-
human cell lines of epithelial and/or mesothelial cells,
and rodent animal models have been useful. Studies have
identified MAPkinase [11-13], cytokines, Akt [11,14],
PKC [15], p53 [10,16] and NF-κB [17,18] signaling path-
ways as important players. Chromosomal translocations,
promoter silencing, point mutations, deletions, and/or
familial genetic susceptibility are also likely to contribute
to a cell's inability to respond appropriately to the geno-
toxic insult of crocidolite [19,20]. The number and com-
plexity of the signaling components identified thus far
mirrors the idea that the asbestos response is not only
related to the presence of iron and the production of ROS,
but also involves receptor-mediated processes. An una-
voidable caveat of trying to combine all the current exper-
imental data lies in the inherent differences that exist
between species and within cell lines, primary cells, and
tumor specimens (reviewed in [21]), and the involvement
of neighboring tissue. The complexity of asbestos
response and the multiple pathologies associated with the
fiber would suggest the need for more systems biology
approaches to the problem.
This study was conducted to begin to elucidate how the
A549 human lung epithelial cell transcriptome is altered
when cells are exposed to crocidolite asbestos at 6 μg/cm2.
An experimental strategy was developed to ensure a statis-
tically robust, comprehensive data set from which global
observations and analyses of specific pathways could be
made. This study extends a previous microarray experi-
ment [22] performed at 2 μg/cm2 where replicates were
not available. Using the more than 2,500 genes that were
differentially regulated by crocidolite in A549 cells, we
were able to: 1) Statistically classify the data set based on
gene ontologies. This analysis revealed significant repre-
sentation by transcriptional corepressor and repressor
activities. Additionally, a significant unique representa-
tion by DNA modification ontologies within a less signif-
icant DNA repair/response ontology was found; 2)
Identify specific novel genes that may play a role in exper-
imentally observed asbestos-induced responses; and 3)
Use a knowledge-based network approach to reveal a
highly integrated series of networks related to cell death,
cancer, cell cycle, cellular growth, proliferation, and gene
expression. Network analysis identified several functional
modules in which previously unidentified genes may play
a central role in the response of cells to asbestos, including
participation from an extensive extracellular set of growth
factors and cytokines. Importantly, by combining
genome-wide transcript changes and functional network
analysis, we have documented a novel global view of the
crocidolite-treated A549 transcriptome, which bears sig-
natures of both proliferation/cell survival and apoptosis/
cell death.
Results and Discussion
Experimental Design
Given the difficulties in obtaining sufficient primary
human lung epithelial cells to study the complex responseBMC Genomics 2008, 9:376 http://www.biomedcentral.com/1471-2164/9/376
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to asbestos, many studies have instead employed the
A549 human adenocarcinoma cell line. In doing so one
must keep in mind that the transformed cell line may not
be entirely applicable to normal human lung cells. How-
ever, all processes noted below are recapitulated in pri-
mary human lung epithelial cells, suggesting that A549
cells represent a valid model system. Importantly, use of a
human cell line avoids the inherent differences that are
seen between individual patients. Alveolar epithelial type
II cells are key participants in inflammation, fibrogenesis,
and carcinogenesis [23] and have been described as the
targets of asbestos-associated lung carcinomas [24].
The conditions used for obtaining the gene expression
profile for crocidolite treated A549 cells were chosen to
mimic conditions where a variety of biochemical observa-
tions have previously been made in our laboratories.
Exposure of A549 cells to 6 μg/cm2 crocidolite for 24
hours had previously been shown to result in the αvβ5
integrin receptor-mediated endocytosis of asbestos fibers
[25], mobilization of iron from the fibers within the cell
[26], upregulation of ferritin protein to combat the iron
overload [27], production of reactive oxygen intermedi-
ates [28], efflux of reduced glutathione [9], DNA damage
[7], PARP cleavage and activation of initiator caspases
[29]. Thus, at 6 μg/cm2  of crocidolite the microarray
results could be related to an extensive body of biochem-
ical information already available in A549 cells. In addi-
tion, this cell line has been used by other investigators for
several studies to explore the mechanisms of DNA dam-
age [30], apoptosis [10], and invasiveness [31]. Use of the
A549 human lung epithelial cell line complements stud-
ies done in mesothelial cells [32] and by the less carcino-
genic chrysotile in bronchial epithelial cells [33]. Our goal
was to extend our results beyond lists of genes and onto-
logical classifications to discover new pathways based on
functional interactions. Rather than diffusing statistical
power by examining differences among multiple time
points and asbestos concentrations, this experiment
focused on the use of chemically defined crocidolite
asbestos, a single concentration of crocidolite versus a
control condition, and a single exposure time. This focus
allowed for three replicates of mRNA from control and
crocidolite-treated cells to be analyzed using the Affyme-
trix HGU133 Plus 2.0 GeneChip to provide the most com-
prehensive whole genome expression profile.
Analysis of the Microarray Data
Graphical checks of the gene expression data revealed a
high-quality data set, with no spatial artifacts in the chip
images, and a high degree of reproducibility within both
the control and treated replicates (Additional File 1).
Using tools described in the Methods Section and a false
discovery rate [34] of 0.05, 2,546 genes with q-values
(FDR-adjusted p-values) less than 0.05 were called statis-
tically significant. These results are represented in a vol-
cano plot (Figure 1).
Crocidolite Induces Large Changes in the Transcriptome of 
A549 Human Lung Epithelial Cells
Among the 54,120 probe sets on the GeneChip, 1808
were significantly up-regulated (492 of which were two-
fold or greater), and 738 were significantly down-regu-
lated (27 of which were two-fold or greater) when A549
cells were exposed to 6 μg/cm2 crocidolite asbestos for 24
h. Of the probe-sets that changed two-fold or greater, 234
correspond to known genes for the up-regulated probe
sets, and 16 of the down-regulated probe sets correspond
to known genes (some genes were represented more than
once on the chip). Genes that increased in expression five-
fold or greater or decreased two-fold or greater and were
associated with q-values less than 0.05 are shown in Table
1. A complete table of all significant genes can be found as
Additional File 2. The observation that most of the expres-
sion changes are upregulated is contradictory to a previ-
ous microarray study in A549 cells [22] which used a
smaller dose of crocidolite (2 μg/cm2). A direct compari-
son of the two data sets was difficult due to differences in
experimental design. Namely, replicates at a single time
point were used in the current study versus single chips
over a time course, and a lower crocidolite concentration,
Volcano plot showing the magnitude of differential expres- sion (log2 fold-change) compared to the measure of statisti- cal significance (-log10 q-value) Figure 1
Volcano plot showing the magnitude of differential 
expression (log2 fold-change) compared to the meas-
ure of statistical significance (-log10 q-value). Color is 
on the density scale, so darker colors indicate over-plotting 
of points. Statistically significant genes are observed above 
the horizontal line, which corresponds to a q-value of 0.05. 
The low variability in the data caused a large number of genes 
(2,546) to be classified as statistically significant.BMC Genomics 2008, 9:376 http://www.biomedcentral.com/1471-2164/9/376
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Table 1: List of genes for which expression increased five-fold or greater or decreased two-fold or greater
Fold Change Gene Symbol Gene Name
115.7 EGR1 Early growth response 1
38.3 FOS v-Fos FBJ murine osteosarcoma viral oncogene homolog
25.3 ATF3 Activating transcription factor 3
19.5 GEM GTP binding protein overexpressed in skeletal muscle
17.1 NR4A2 Nuclear receptor subfamily 4, group A, member 2
16.6 IL8 Interleukin 8
15.9 FST Follistatin
15.6 PPP1R15A Protein phosphatase 1, regulatory (inhibitor) subunit 15A
13.7 STC1 Stanniocalcin 1
12.1 MAFF v-Maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian)
11.2 CXCL2 Chemokine (C-X-C motif) ligand 2
10.4 TNFAIP3 Tumor necrosis factor, alpha-induced protein 3
9.4 MXD1 MAX dimerization protein 1
9.1 ARID5B AT rich interactive domain 5B (MRF1-like)
9.0 NR4A3 Nuclear receptor subfamily 4, group A, member 3
8.6 JUN v-Jun sarcoma virus 17 oncogene homolog (avian)
7.8 LOC153222 adult retina protein
7.4 BRE brain and reproductive organ-expressed (TNFRSF1A modulator)
7.2 MCTP1 Multiple C2 domains, transmembrane 1
7.2 DDIT3 DNA-damage-inducible transcript 3
7.2 FOSB FBJ murine osteosarcoma viral oncogene homolog B
7.1 GDF15 Growth differentiation factor 15
6.9 CITED2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
6.9 DUSP6 Dual specificity phosphatase 6
6.6 CXCL1 Chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
6.5 IL24 Interleukin 24
6.3 SPRY2 Sprouty homolog 2 (Drosophila)
6.1 PTGS2 Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
6.0 KLF6 Kruppel-like factor 6
6.0 IL11 Interleukin 11
5.6 IRAK2 Interleukin-1 receptor-associated kinase 2
5.5 IL6 Interleukin 6 (interferon, beta 2)
5.5 HIST1H4H Histone 1, H4h
5.4 FNIP1 folliculin interacting protein 1
5.3 HIST2H2BE Histone 2, H2be
5.2 MCL1 Myeloid cell leukemia sequence 1 (BCL2-related)
5.1 DUSP10 Dual specificity phosphatase 10
5.1 DHRS2 Dehydrogenase/reductase (SDR family) member 2
5.1 SYNE1 Spectrin repeat containing, nuclear envelope 1
5.1 HAS2 Hyaluronan synthase 2
5.1 PER1 period homolog 1 (Drosophila)
5.1 ZBTB10 zinc finger and BTB domain containing 10
-2.0 FN1 Fibronectin 1
-2.0 BCL2L11 BCL2-like 11 (apoptosis facilitator)
-2.0 COL5A1 collagen, type V, alpha 1
-2.0 VAV3 vav 3 oncogene
-2.0 CSRP2BP CSRP2 binding protein
-2.0 PRSS23 protease, serine, 23
-2.1 NRP2 Neuropilin 2
-2.1 DAPK1 Death-associated protein kinase 1
-2.1 CDH1 Cadherin 1, type 1, E-cadherin (epithelial)
-2.2 ST8SIA4 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4
-2.2 RNASE4 Ribonuclease, RNase A family, 4
-2.2 FGG Fibrinogen gamma chain
-2.1 STAT4 Signal transducer and activator of transcription 4
-2.1 NTRK3 Neurotrophic tyrosine kinase, receptor, type 3
-2.3 PCDH9 Protocadherin 9
-2.2 CYP4F3 Cytochrome P450, family 4, subfamily F, polypeptide 3
-2.2 ST8SIA4 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4BMC Genomics 2008, 9:376 http://www.biomedcentral.com/1471-2164/9/376
Page 5 of 17
(page number not for citation purposes)
which is a likely cause for some differences. Cells exposed
to asbestos may demonstrate a hierarchical oxidative
stress response [35]. Additionally, small amounts of
asbestos have been shown to result in proliferation [24].
This may be attributed to a transient response to an
increase in iron, which is limiting in cells in culture. How-
ever, comparison of individual expression changes in our
data set to other known experimental results (discussed
below) demonstrated that our data set is consistent with
the literature.
Hierarchical clustering analysis (Figure 2A) of our data set
showed that the majority of the up-regulated probe sets
clustered together in four different hierarchical clusters.
The down-regulated probe sets were mainly in one hierar-
chical cluster, but had several individual genes spread
throughout the dendrogram. Within the four up-regulated
clusters, 24 genes that were upregulated 5-fold could be
mapped by functional String analysis shown in Fig 2B.
Most of the gene products are connected; i.e., could be
linked functionally by way of known molecular interac-
tions. Three major pathways (MAPK, JNK/SAPK and
cytokine-cytokine receptor interactions) are represented
in the cluster. This result is consistent with what is cur-
rently known about the effect of asbestos in epithelial and
mesothelial cells. When the down-regulated genes were
functionally clustered, only two (fyr and uvo) out of 16
had a connection (data not shown).
Validation of the Microarray Data
Validation of the microarray data was confirmed by quan-
titative RT-PCR on four of the genes (Egr1, ATF3, c-Jun,
and JunB) and was further corroborated with previously
noted results from experiments using human cells/cell
lines (Table 2). Quantitative RT-PCR also demonstrated
that increases in Egr-1, ATF3, c-Jun, and JunB message
occurred after 6 hours and continued to increase through
24 hours (data not shown). Increased mRNA expression
from ATF3, c-Jun, and JunB was also observed by quanti-
tative RT-PCR in primary human epithelial cells from
small airways (SAEC) treated with crocidolite (data not
shown). Increased protein expression in A549 cells
exposed to crocidolite was observed for ATF3, c-Jun, and
JunB (data not shown). Finally, previous results using
asbestos-treated A549 cells have demonstrated increased
mRNA and/or protein levels for IL8, TP53, HMOX1,
CDKN1A, SOD2 and c-myc (see Table 2 for additional ref-
erences). The reproducibility of the microarray replicates,
the significance level of the expression changes, and the
validation by quantitative RT-PCR suggest that a highly
useful and validated data set was obtained in this study.
Furthermore, the large number of significant genes
allowed us to perform a comprehensive analysis of the
crocidolite-induced transcriptome in human lung epithe-
lial cells.
Specific Changes in the Crocidolite-Treated 
Transcriptome
Although it is clearly established that asbestos induces
DNA damage in both primary cells and cell culture lines,
the literature illustrates that the molecular mechanism
underlying this process and how the fate of the cell is dic-
tated are multifaceted. Although ROS are intimately tied
to the mechanism of asbestos-induced fibrosis and car-
cinogenesis, ROS alone do not offer a complete under-
standing of the asbestos response. In order to identify
genes for which expression level changes are specific for
crocidolite compared to oxidative stress, we compared our
data set to expression changes that occur in A549 cells
when exposed to hydrogen peroxide. In a previous study
that documented changes in the A549 cell transcriptome,
Cotgreave and co-workers [36] showed that treatment of
A549 cells with hydrogen peroxide results in DNA dam-
age and apoptosis. Both hydrogen peroxide and crocidol-
ite asbestos induced the upregulation of TNFRS10B,
PPP1R15A, GADD34, CDKN1A, BTG2, DUSP1, DUSP5,
DUSP14, SDC4, GDF15, IL8, ADM, FST, IER3, FOS,
HMOX1, ATF3, and ZFP36. Therefore, expression changes
in these genes may represent a response to an oxidative
stress. Several unique genes that are differentially regu-
lated in the crocidolite data set are noted in Table 1 and
include some genes which are associated with carcinogen-
esis such as STC1, IL6, FN1, BRE, and PTGS2. Differences
between the hydrogen peroxide-treated and crocidolite-
treated transcriptomes may be due to the additional iron
released from fibers, present in cells treated with crocido-
-2.3 MAP2K6 Mitogen-activated protein kinase kinase 6
-2.3 LXN latexin
-2.3 TM4SF20 transmembrane 4 L six family member 20
-2.4 AKR1C1///AKR1C2 Aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-
hydroxysteroid dehydrogenase)///aldo-keto reductase family 1, member C2 
(dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III)
-2.7 SLC40A1 Solute carrier family 40 (iron-regulated transporter), member 1
A549 human lung epithelial cells were exposed to crocidolite asbestos at 6 g/cm2 for 24 h. Genes for which expression levels increased 5.0 fold or 
greater, or decreased 2.0 fold or greater, having q values less than 0.05 are shown. Probe sets associated with products of unknown function were 
not included. Bold-faced genes were not observed in the statistically upregulated expression profile of hydrogen-peroxide-treated A549 cells [36]. 
A list of all genes for which expression levels changed 2.0 fold or greater can be found as Additional File 2.
Table 1: List of genes for which expression increased five-fold or greater or decreased two-fold or greater (Continued)BMC Genomics 2008, 9:376 http://www.biomedcentral.com/1471-2164/9/376
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Unsupervised hierarchical clustering analysis of A549 probe sets in which the expression was altered by crocidolite Figure 2
Unsupervised hierarchical clustering analysis of A549 probe sets in which the expression was altered by croci-
dolite.(A) The main dendogram represents the intensity of each probe set in relation to the entire data set with green being 
low and red being high. Four major clusters of upregulated genes and two clusters of downregulated genes were observed and 
are shown as bracketed dendograms where the color represents the intensity of each probe set in relation to each specific 
cluster. (B) STRING analysis using the genes within the upregulated clusters demonstrated a functional relationship between 
24 of the genes which encompassed cytokine, MAPkinase and JNK/SAPK signaling pathways.
EGR1
ATF3
JUN
DUSP10
FOS
IL11
CXCL2
CXCL1
IL8
IL6
FOSB
DDIT3 SPRY2
DUSP6
MCL1
HAS2
PTGS2
CITED2
KLF6
TNFAIP3
IRAK2 NR4A2
PPP1R15A
GDF15
Cytokine-cytokine receptor
 interactions
MAPK signaling pathway
Other
A BBMC Genomics 2008, 9:376 http://www.biomedcentral.com/1471-2164/9/376
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Table 2: Validation of the microarray data from crocidolite-treated human A549 cells
Gene Alias for Protein Product Affymetrix* (fold change) 
this study
QRT-PCR (fold change) this 
study
Changes in mRNA levels in 
human cells observed by other 
groups
EGR1 Egr1 115.7 281.7 ± 3.8
ATF3 ATF3 25.3 23.7 ± 0.1
c-Jun c-Jun 8.6 10.5 ± 0.7
JunB JunB 2.2 3.6 ± 0.2
IL8 Interleukin 8 16.6 N.D. Increased [73]
TP53 p53 1.8 N.D. Increased [16,74]
SOD2 Mn-SOD 2.2 N.D. Increased [75]‡
HMOX1 Heme oxygenase 1 2.1 N.D. Increased [75,76]†
c-myc myc 2.0 N.D. Increased [77]
CDKN1A p21, Cip1 1.9 N.D. Increased [16,74]
*represents significantly greater than control, q less than 0.05; N.D., not determined
† chrysotile-treated A549 human lung epithelial cells
‡ crocidolite-treated human pleural mesothelial cells
Gene ontology analysis of the (A) Biological Processes and (B) Molecular Functions most affected by crocidolite in A549 cells Figure 3
Gene ontology analysis of the (A) Biological Processes and (B) Molecular Functions most affected by crocidol-
ite in A549 cells. In (C) a global test to identify ontologies related to transcription was used to pinpoint significant functions. 
The p-values for each of the GO terms (abbreviated as the last four digits of each ontology's identifier) has been overlaid onto 
the hierarchical tree where the darkest gray node represents a p = 0.034 and the lightest represents a p = 0.017.BMC Genomics 2008, 9:376 http://www.biomedcentral.com/1471-2164/9/376
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lite, or reactive nitrogen species, changes in glutathione
content and/or the involvement of processes initiated at
the cell surface by the fiber. It will be very interesting to
investigate if these apparent crocidolite-specific gene reg-
ulations play a role in crocidolite-induced cytobiological
endpoints.
Ontological Analysis of the Crocidolite-Treated Lung 
Transcriptome
In order to identify themes in the global expression pat-
tern of crocidolite-treated A549 cells, we used Gene
Ontology (GO) classification. The differentially expressed
genes (up-regulated/down-regulated ± 2-fold with p-val-
ues less than 0.2) were analyzed using Onto-Express http:/
/vortex.cs.wayne.edu/. The Biological Process tree was
expanded to the fourth tier in the hierarchy as a balance
between specificity and coverage. Processes affected by
crocidolite are shown in Figure 3A. Within the Cellular
Metabolism classification, processes involved in transcrip-
tion and phosphorus metabolism were highly repre-
sented. Expansion of Molecular Functions to the third tier
revealed a large number of genes with functions related to
transcription (over-represented in Protein binding (Figure
3B)). This observation was expanded upon by performing
a global test [37-39] to identify specific gene ontologies
related to transcription, where the expression levels of all
the genes in the ontology give useful information for pre-
dicting the clinical outcome (or in this case, a cellular out-
come of crocidolite exposure). Ontologies of particular
interest related to transcription factor activity
(GO:0003700) are summarized in Figure 3C, with nodes
colored to correspond to global test p-values; the lighter
nodes have lower p-values. To reduce visual clutter, only
the last four digits of each ontology's identifier are
reported in Figure 3C. The ontological analysis illustrates
that transcriptional corepressor activity and repressor
activity are highly represented in the data set. Overall the
transcriptome of crocidolite-treated human lung epithe-
lial (A549) cells is heavily populated by gene products
associated with transcription.
We also noted that DNA repair terms were not highly rep-
resented in the data set. Although this result was initially
surprising, we noted that the transcriptome of A549 cells
exposed to hydrogen peroxide, which also induces DNA
damage, was also underrepresented in DNA repair terms
[36]. In order to gain a better understanding of how the
transcriptome of crocidolite-treated A549 cells is reorgan-
ized in response to the resulting DNA damage, the results
of the global test discussed above were also applied to
ontologies related to DNA damage/repair. Although this
analysis (see Additional File 3) confirms the overall obser-
vation that many of the processes related to DNA repair/
damage are not highly represented, the analysis also high-
lights specific nodes in the GO tree related to DNA dam-
age-induced phosphorylation (GO:6975), DNA
dealkylation (GO:6307), DNA methylation (GO:6306),
and DNA alkylation (GO:6305). In light of the several
studies directed at linking promoter methylation status
and carcinogenesis (reviewed in [40]), it is interesting to
point out that in as little as 24 hours of crocidolite expo-
sure, the A549 transcriptome may be poised to affect the
DNA methylation status that is associated with lung can-
cer pathogenesis.
Identification of Novel, Putative Crocidolite-Related 
Genes
Even though this study was initiated to understand the
broad changes that occur in the lung transcriptome upon
crocidolite exposure, we also sought to identify novel
genes that had no previous association with crocidolite
and to identify genes that may be downstream targets of
well-known crocidolite-related players. Given the com-
plex effects that asbestos has on the lung system, we
expected that a systems biology approach may provide
novel avenues to study. NR4A1,  NR4A2, and NR4A3
belong to the steroid nuclear hormone receptor super-
family of immediate early genes that are induced by
serum, growth factors and receptor engagement and are
thus implicated in cell mitogenic responses. Although pre-
viously characterized as pro-survival, studies have also
suggested an important role for these receptors in cell
transformation and tumorigenicity via their anti-apop-
totic and pro-apoptotic functions [41]. Thus, depending
on cellular context, these gene products may serve as
switches in determining cell fate. All three members of
this family show increased expression in our data set
(Additional File 2) but have not previously been impli-
cated in crocidolite-induced pulmonary toxicity.
Modulation of apoptosis can also be affected by BRE
(brain and reproductive organ-expressed protein), a
stress-modulating protein also known as TNFRSF1A mod-
ulator. BRE expression was upregulated >7-fold in croci-
dolite-treated A549 cells. Exogenous overexpression of
BRE can attenuate intrinsic apoptosis and promote
growth of the transfected Lewis lung carcinoma line in
mice [42] which is consistent with the recent finding that
BRE protein is overexpressed in human hepatocellular car-
cinomas [43]. Given the ability of BRE to interact with
both Fas [44] and the TNF receptor 1 [45], and the obser-
vation that TNFα can attenuate asbestos cytotoxicity in
mesothelial cells [17], it will be very interesting to investi-
gate possible roles of BRE in crocidolite-treated human
lung cells. Also noteworthy is the upregulation of several
"early response" NF-κB targets [46] in our dataset (Addi-
tional File 2) including TNFAIP3, IL8, IL6, CXCL1,
CXCL2, CXCL3, PTGS2, and PLAU. Activation of the NF-
κB pathway is thought to play a critical role in cell survivalBMC Genomics 2008, 9:376 http://www.biomedcentral.com/1471-2164/9/376
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in asbestos-treated cells [17], but only a few of the down-
stream targets of NF-κB have been identified.
The relationship between asbestos and calcium has
received little attention in recent years, but the initial stud-
ies suggest that calcium may have an important role to
play (reviewed in [47]). Perhaps most compelling is the
ability of the calcium-chelator Quin-2 to prevent crocido-
lite-induced DNA breaks [48]. Additionally, several play-
ers in the asbestos response are regulated by calcium
levels, e.g., protein kinase C [15]. We were therefore inter-
ested in determining if the crocidolite-treated transcrip-
tome demonstrated any clues regarding the regulation of
calcium homeostasis. We observed that expression of
MCTP1 and STC1 were both upregulated in our data set
by 7.3- and 12.9-fold, respectively. MCTP1 is a transmem-
brane protein that binds calcium ions via C2 domains.
Unique properties of this protein suggest that these pro-
teins function in Ca2+ signaling at the membrane [49].
Stanniocalcin 1 (STC1) has long been studied as a regula-
tor of both phosphate and calcium homeostasis in bony
fish, but has recently received attention in mammalian
systems. STC1 is a glycoprotein present in a variety of
mammalian tissues where it can function as a regulator of
gene expression and modulator of transendothelial cell
migration [50], and can also affect cellular metabolism by
perturbing mitochondrial electron transport chain and
mitochondrial calcium transport [51]. STC1 affects cal-
cium homeostasis in the heart [52,53] and the brain [54].
Growing evidence also points to a correlation between
STC1 expression and the development of human cancers
[55,56]. Quantitative RT-PCR also demonstrated a 30.7 ±
5.1-fold increase in STC1 message in primary human
SAEC exposed to crocidolite.
Finally, in recent years a significant number of studies
have been directed at understanding how the disruption
of dynamic chromatin remodeling is linked to carcino-
genesis. Mechanisms including the previously mentioned
DNA methylation status and the use of histone modifica-
tions have led to the discovery of prognostic biomarkers
[57] and the use of HDAC inhibitors as cancer therapeu-
tics [58]. It is of little surprise then to find several differen-
tially regulated genes in crocidolite-treated A549 cells that
could participate in chromatin remodeling including the
Jumonji domain histone demethylases JMJD1C, JMJD3
and JMJD1A, all of which showed increased expression
(Supplementary Table 1). Other genes of interest are dis-
cussed below.
Pathway Analysis Provides Unique View of Function-Based 
Networks in Crocidolite-Treated Cells
In order to extract novel biological insight from the large
number of genes upregulated/downregulated in our
study, we employed a structured network knowledge-
based approach to analyze genome-wide transcriptional
responses in the context of known functional interrela-
tionships among proteins, small molecules and pheno-
types http://www.ingenuity.com. Networks are generated
not only based on functional interactions but also statisti-
cal likelihood. Genes/gene products are represented as
nodes and are color-coded to represent fold-change in
expression level. Interactions between nodes are desig-
nated as edges, or lines, and represent physical, transcrip-
tional, and enzymatic interactions.
Statistically Significant Function-based Networks and Pathways
Using expression changes that were differentially regu-
lated by ± 2-fold and having p values less than or equal to
0.01, Ingenuity Pathway® Analysis demonstrated a highly
complex set of 16 interconnected networks. These net-
works were related to cell death, cancer, cell cycle, cellular
growth and proliferation, and gene expression. All net-
works had at least one gene in common and many had
two genes in common, underscoring the interplay and
complexity of the crocidolite response. The top scoring
network (Figure 4A) was composed of genes related to cell
death, organism survival and cancer, and highlighted
MYC, PDGF BB, and EPAS1/HIF2 as prominent nodes. In
particular, EPAS1 was a node for four genes whose expres-
sion levels changed 6-fold or greater. EPAS1 (endothelial
PAS domain protein-1, or HIF2α) is one of the transcrip-
tion factors which belong to the basic helix-loop-helix
PAS family. It shares sequence similarity to HIF-1α and
analogously to HIF-1α, regulates transcription of VEGF
and is observed to be upregulated at both the message and
protein levels in A549 cells as a result of hypoxia [59].
Prognostic significance of increased levels of EPAS1
mRNA and/or protein has been observed in liver [60] and
colon [61] cancers. Interestingly, EPAS1 -/- mice show
impaired reactive oxygen species homeostasis [62], which
may be linked to the role of EPAS1 in maintaining mito-
chondrial homeostasis [63], creating a hypothetical link
between EPAS1 function and response to crocidolite.
This first network (Figure 4A) is linked to the Nrf2-medi-
ated oxidative stress pathway (one of the top scoring
canonical pathways in our data set shown in Figure 4B)
via the MAFF node. Cellular use of this canonical pathway
has been linked to tumor cell survival by maintaining cel-
lular redox homeostasis and protection against oxidative
insult. Heterozygous Nrf2 (+/-) mice exposed to crocidol-
ite fibers exhibit accelerated development of malignant
mesotheliomas compared to wild-type littermates [64].
Several of the known Nrf2 targets did not show significant
changes in expression levels in our data set (data not
shown). Although not all of the downstream targets of
NRF2 were differentially upregulated upon exposure to
crocidolite at 6 μg/cm2, message levels for many of the
Nrf2 targets were present in above average amounts onBMC Genomics 2008, 9:376 http://www.biomedcentral.com/1471-2164/9/376
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both the control and treated chips. Furthermore, data sug-
gests that this pathway may be activated in a hierarchical
fashion [35], dependent on exposure. Selective activation
of the Nrf2 pathway may contribute to carcinogenicity of
the crocidolite fibers, while dysfunctional constitutive
activation of Nrf2 [65] has been observed in non-small-
cell lung cancer.
The topscoring network illustrates the interplay between
processes involved in both cell survival/proliferation and
cell death/apoptosis when A549 cells are exposed to croc-
idolite. Activation of the Nrf2 cytoprotective pathway in
the transcriptome of crocidolite-treated A549 cells is
imperfect. The observed selective Nrf2 target expression
would define an environment that is rich in hydrogen per-
oxide and incapable of redox homeostasis.
A Global View of the Functional Networks in A549 Cells in Response 
to Crocidolite
Another approach to gain insight about the functional sig-
nificance of the global changes in crocidolite-induced
gene expression is to merge the individual networks and
then identify nodes that are used frequently. Over 500
nodes were observed within the 16 networks, making
presentation of the global cellular network difficult.
Instead, the top five networks were merged using all
known interactions in the knowledge-based database and
the nodes arranged according to subcellular location
resulting in Figure 5A. This representation comprises ~150
genes and their interactions and illustrates a transcrip-
tome encoding an array of extracellular growth factors and
cytokines. Even though a population of exposed cells
undergoes apoptosis, some cells may survive and be stim-
Spatial depiction of the top scoring network and canonical pathways detected in crocidolite-treated A549 cells by Ingenuity  Pathway® Analysis Figure 4
Spatial depiction of the top scoring network and canonical pathways detected in crocidolite-treated A549 cells 
by Ingenuity Pathway® Analysis. The network was algorithmically generated based on the connectivity of each of the tran-
scripts and the molecular interaction knowledge base. Each node represents a gene or gene product for which mRNA expres-
sion was upregulated (red) or downregulated (blue) in crocidolite-treated A549 cells. Edges/lines connecting the nodes 
represent molecular interactions between genes and/or gene products and are supported by at least one reference from the 
literature, a textbook, or from canonical pathway information stored in the Ingenuity Pathways Knowledge Base. The Nrf2-
mediated oxidative stress canonical pathway identified by Pathway Analysis software shows differential upregulation of select 
genes within the cytoprotective arsenal.BMC Genomics 2008, 9:376 http://www.biomedcentral.com/1471-2164/9/376
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ulated to proliferate based on factors released from neigh-
boring cells. Several high impact nodes including MYC,
JUN, Akt, p38, and PDGF BB, all of which are established
players in the response to asbestos, are also present. Other
genes that formed prominent nodes in the prototypical
cell or adjacent networks included PTGS2,  SMARCA4,
PTEN, and E2F1. They are shown as separate networks for
clarity in Figures 5B, C and 5D. The PTGS2 product, Cox-
2, PTEN and E2F1 have previously been implicated in car-
cinogenesis, but their roles in the epithelial cell response
to asbestos have not been studied. Brg1, the protein prod-
uct of SMARCA4, is a SWI/SNF related chromatin remod-
eling factor which recognizes acetylated lysine groups
through bromo domains and is involved in cell growth
arrest and apoptosis. Oxidative stress and TNF-α induce
histone acetylation and NF-κB/AP-1 activation in alveolar
epithelial cells [66] suggesting a potential mechanism to
alter gene transcription in lung inflammation using Brg1.
Inspection of the network surrounding the E2F1  node
identified several genes whose expression was differen-
tially regulated by asbestos that also demonstrated molec-
ular interactions with TNF. Given the relationship
between TNF and NF-κB activation observed in mesothe-
lial cells exposed to crocidolite [17], and the recent iden-
tification of E2F1 as a transcriptional activator recruited
by NF-κB [67], investigation into the role that E2F1 plays
in human lung epithelial cells exposed to crocidolite
should be forthcoming.
This analysis has provided the first function-based global
view of the crocidolite-treated A549 transcriptome. Sev-
eral new candidate crocidolite-related genes were identi-
fied in the context of experimentally observed findings.
Apparent from the global analysis is a transcriptome bear-
ing signatures of both apoptosis/cell death and cell sur-
vival/proliferation.
Using Pathway Analysis to Probe the Role of p53
Pathway Analysis also detected significance in p53-medi-
ated processes. This result is consistent with the observa-
tion that both amosite and crocidolite induce p53
activation. Specifically, Kamp and co-workers who
showed that p53 mediates amosite-induced apoptosis
through mitochondrial dysfunction in A549 cells [10].
Although the mechanism is not clear, ROS generated by
the mitochondria, p53-mediated transcription, and trans-
location of p53/BAX appear to be necessary components
for apoptosis to occur. The authors suggested that other
pro-apoptotic pathways may also be activated and a more
thorough study of p53-targeted transcription pathways
was needed. Figure 6 shows a scheme representing these
findings overlaid with the expression changes from our
data set and molecular interactions identified through
network analysis. Since it is unknown whether ROS detec-
tion and p53 activation require new protein synthesis, we
did not restrict this part of the analysis to differentially
regulated genes. Several genes whose expression depends
on p53 could be identified that were associated with both
apoptosis and proliferation or survival. These results may
reflect the expected heterogeneity in the population of
cells after exposure to crocidolite, as discussed previously.
Although crocidolite induces apoptosis in many of the
cells, the bulk transcriptome shows evidence that tran-
scripts are present which could tip the balance in favor of
cell cycle arrest and/or cell survival or proliferation. Mes-
sage levels of the p53-induced molecular switch p21CIP/
WAF1  and KLF4 were upregulated in crocidolite-treated
cells. Together these two products can have an anti-apop-
totic effect [68].
The importance of p53 in mediating apoptosis in asbes-
tos-treated A549 cells has been documented [10]. Analysis
of p53 targets upregulated in the crocidolite-treated A549
transcriptome identified several candidate genes that may
function in the observed apoptosis. Interestingly, we also
identified several p53 targets associated with cell survival/
proliferation. This suggests that p53 may be an important
molecular turning point in the decision of crocidolite-
treated cells to undergo apoptosis or to proliferate, even in
the presence of damaged DNA.
Conclusion
In this study, we have provided a statistically robust and
comprehensive global gene expression profile of A549
human lung epithelial cells exposed to crocidolite asbes-
tos. Our data reveal a much altered transcriptome in
which a large number of genes show upregulated expres-
sion. Crocidolite-treated A549 cells are rich in transcripts
encoding extracellular growth factors and cytokines and
intracellular regulators/mediators of transcription. A glo-
bal view based on functional molecular interactions illus-
trated an intricate network of paths associated with both
apoptosis and proliferation/cell survival. This network
allowed for the identification of novel, putative crocidol-
ite-related genes, leading to several new hypotheses
regarding genes which are important in the response of
human lung epithelial cells to crocidolite.
Our analysis demonstrates the power of a functional net-
work genomics approach to 1) identify and explore rela-
tionships between genes of known importance 2) identify
novel candidate genes, and 3) observe the complex inter-
play between genes/gene products that function in seem-
ingly different processes. This study represents the first
function-based global approach toward understanding
the response of human lung epithelial cells to the carcin-
ogen crocidolite. We have provided graphical representa-
tions of the highly interconnected networks that will be
instrumental in modeling the impact of new research
findings. Our global function-based approach introducesBMC Genomics 2008, 9:376 http://www.biomedcentral.com/1471-2164/9/376
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Pathway analysis of representative genes involved in the response of A549 cells exposed to crocidolite Figure 5
Pathway analysis of representative genes involved in the response of A549 cells exposed to crocidolite. In (A) 
the top five scoring networks were merged to create a cellular model consisting of ~150 genes for which expression levels 
changed ± 2-fold and demonstrated p-values less than 0.01. Nodes representing genes are colored red for upregulation or blue 
for downregulation and the intensity of the color reflects the degree of up- or downregulation. Lines connecting the nodes are 
indicators of interactions found in the knowledge database or current literature. In (B) and (C) the networks surrounding 
PTGS2, SMARCA4, and PTEN have been expanded for clarity. In (D) the relationship between E2F1 and TNF is observed.BMC Genomics 2008, 9:376 http://www.biomedcentral.com/1471-2164/9/376
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new insights and novel avenues which can now be inves-
tigated in more detail to understand the effects of crocido-
lite on the human lung.
Methods
Reagents and Antibodies
Crocidolite was obtained from Dr. Richard Griesemer,
NIEHS/NTP. The chemical formula for crocidolite is
Na2FeIII
2(FeII, Mg)3Si8O22(OH)2. It has a mean length of
10 μm, a density of 3.2–3.3 g/cm3 and contains 27% iron
by weight [69]. A custom prepared Ham's F-12 cell culture
medium free of iron salts and 0.5% trypsin with 0.2%
EDTA were obtained from Invitrogen Inc. (Carlsbad, CA).
Fetal bovine serum (FBS) was purchased from Hyclone
(Logan, UT). Antibodies for Egr-1 (sc-189) and ATF3 (sc-
188) were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA) and the antibody for β-actin was pur-
chased from Sigma (St. Louis, MO). Anti-rabbit and anti-
mouse enzyme-conjugated secondary antibodies were
purchased from Jackson Immunoresearch Laboratories
Inc. (West Grove, PA). Primers were purchased from
Asbestos induces a p53-mediated response in A549 lung cells Figure 6
Asbestos induces a p53-mediated response in A549 lung cells. Experimental data is indicated by the thick blue edges 
and is discussed in more detail in the text. Known p53 targets which may have a role in the asbestos response and their biolog-
ical effects are shown using thin gray lines. Nodes are color coded shades of red when expression levels increased and shades 
of blue when expression levels decreased. Nodes surrounded by dashed lines represent genes/gene products which were not 
represented on the gene chip but which displayed a functional relationship to queried nodes.BMC Genomics 2008, 9:376 http://www.biomedcentral.com/1471-2164/9/376
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IdtDNA (Coralville, IA). All remaining reagents were pur-
chased in the highest purity possible.
Cell Culture and Treatment
A549 cells were purchased from American Type Culture
Collection and grown in F12 medium without iron, with
10% FBS and 50 μg/mL gentamicin (BioWhittaker, Walk-
ersville, MD). Cells were plated for treatments at a concen-
tration of 20,000 cells/cm2 and incubated 24 h before
treatment. For all treatments, medium was removed and
replaced with either fresh medium (for control samples)
or medium containing the appropriate stimulus (treated
samples). For crocidolite treatments, fibers were sus-
pended in sodium bicarbonate at a concentration of 1
mg/mL and immediately diluted to a final concentration
of 6 μg/cm2 in complete medium. Sodium bicarbonate is
used specifically to avoid iron mobilization in the media
before the fibers can by endocytosed and maintains the
pH [26]. These are the exact same conditions and method-
ologies used previously in several other studies [9,11,25-
27].
RNA Extraction and Use of DNA Microarrays
mRNA was isolated from cells at passage 9 using TRIzol®
reagent from Invitrogen (Carlsbad, CA) following manu-
factures directions. This procedure yielded RNA of both
high quantity and quality, as verified by both the A260/
A280 ratio (> 1.8) and the Agilent 2100 Bioanalyzer (Agi-
lent Technologies, Palo Alto, CA). The extracted RNA was
processed by the Affymetrix core service at the Center for
Integrated BioSystems, Utah State University (CIB-USU;
Logan, UT). RNA was processed as per the manufacturer's
instructions (Affymetrix Inc., Santa Clara, CA) for the first-
strand cDNA synthesis and amplification, followed by
cDNA synthesis and labeling. The cDNA was hybridized
overnight to the HGU133-Plus2.0 Human Genome 2.0
genechips and post-hybridization washing, detection and
data collection were performed as per manufacturer's
instructions. Three biological replicates were performed.
Each replicate consisted of a control plate and a crocidol-
ite-treated plate. All experiments were done at passage 9.
Statistical Analyses
Using tools from the Bioconductor project [70], the data
were pre-processed using the RMA algorithm [71], and a
test for differential expression between control and
treated (crocidolite-exposed) conditions was performed
using the moderated t-statistic from the limma/eBayes
approach [72]. The raw p-values from this test were
adjusted to control the false discovery rate [34] at 0.05.
Dendrograms (Figure 2) were drawn by Hierarchical Clus-
tering Explorer (HCE; http://www.cs.umd.edu/hcil/hce/
hce3.html) software version 3.0 to summarize RMA-nor-
malized data after averaging across replicates. The cutoff
value for minimum levels of gene expression was based
on the whole genome expression profiles generated by
HCE. The median cutoff value was set at the software-cal-
culated median of gene expression and was colored black.
The data were further subdivided into gene functional
classes that had been annotated by the Human Genome
Database. Each class was then clustered separately and the
determined cutoff values were applied to generate colored
expression maps for each individual class for ease of visu-
alization. In addition, a global test [37-39] was used to
identify gene ontologies of interest, where the expression
levels of the genes in the ontology were statistically signif-
icant (p-value less than 0.05) for predicting the clinical
outcome (crocidolite exposure). STRING analysis was per-
formed at http://string.embl.de/ using default parameters.
Quantitative RT-PCR
mRNA was isolated using TRIzol® reagent from Invitrogen
(Carlsbad, CA) following manufactures directions. DNase
from the RNAqueous®-4PCR kit (Ambion Inc., Austin, TX)
was added to eliminate genomic DNA and removed fol-
lowing the manufacture protocol. cDNA was transcribed
using SuperScript™ II Reverse Transcriptase (Invitrogen
Inc., Carlsbad, CA). Specificity was confirmed by perform-
ing a melting curve on the final amplicons and running
the amplicons on a 2% agarose gel. All qRT-PCR samples
were also run on samples without reverse transcriptase to
confirm the product was from mRNA, not DNA, and all of
these samples showed no amplicon. Three different dilu-
tions of cDNA were used to confirm that the samples were
in the linear range.
Western blot analysis
Cells were harvested with trypsin and then lysed using
RIPA buffer (0.15 M NaCl, 50 mM Tris, pH 7.2, 1% deox-
ycholate, 1% Triton X-100, 0.1% SDS) containing pro-
tease inhibitors (30 μL/mL aprotinin, 4 μg/mL leupeptin,
4 μg/mL soybean trypsin inhibitor, 0.1 mM PMSF and 1
μM benzamidine). After incubation on ice for 30 min,
cells were centrifuged for 10 min at 8200 × g to remove
cellular debris. Protein concentrations were determined
using the Bradford method (Bio-Rad Laboratories, Her-
cules, CA). Cellular protein (50 μg) was analyzed using
SDS-PAGE (10–15%) and transferred to polyvinyl difluo-
ride (PVDF) membranes. Primary antibodies were diluted
1:200 in 5% dried milk in TTBS and incubated for 1 h at
room temperature. Secondary antibodies were diluted
1:5000 and incubated for 1 h at room temperature. Blots
were visualized using ECL Plus reagent from GE Health-
care Life Sciences (Piscataway, NJ).
Pathway Analysis
Data were analyzed through the use of Ingenuity Path-
ways (Ingenuity®  Systems, http://www.ingenuity.com).BMC Genomics 2008, 9:376 http://www.biomedcentral.com/1471-2164/9/376
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The asbestos data set with gene identifiers and corre-
sponding expression values was uploaded into the appli-
cation. Each gene identifier was mapped to its
corresponding gene object in the Ingenuity Pathways
Knowledge Base. A cutoff of p < 0.01 was set to identify
genes whose expression was significantly differentially
regulated by ± 2-fold. These genes, called focus genes,
were overlaid onto a global network developed from
information contained in the Ingenuity Pathways Knowl-
edge Base. Networks of these focus genes were then algo-
rithmically generated based on their connectivity.
Biological functions associated with these focus genes
were identified using the Functional Analysis using the
Ingenuity Pathways Knowledge Base. Fischer's exact test
was used to calculate a p-value determining the probabil-
ity that each biological function assigned to the data set
was due to chance alone. Networks are graphical represen-
tations of the molecular relationships between genes/gene
products. Genes or gene products are represented as
nodes, and the biological relationship between two nodes
is represented as an edge (line). All edges are supported by
at least one reference from the literature, a textbook, or
from canonical pathway information stored in the Inge-
nuity Pathways Knowledge Base.
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